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94Imaging for Planning of Cardiac Resynchronization Therapy
Cardiac resynchronization therapy (CRT) is a novel therapy for patients with refractory heart failure (HF).
Large clinical trials evaluating CRT have demonstrated significant improvements in cardiac survival,
decreases in recurrent HF hospitalization, and improvements in indexes of quality of life. Although
numerous mechanisms are involved in CRT’s therapeutic effects, correction of both interventricular and
intraventricularmechanical dyssynchrony has been postulated as the keymechanism. To date,most large
randomized controlled trials evaluating CRT have identified dyssynchronous patients on the basis of
prolongation of the QRS complex from the baseline electrocardiogram. Concerns have been raised
regarding the use of this measure for patient selection, stemming from a significant 30% to 40% nonre-
sponse rate to CRT. Because of the cost and invasive nature of CRT, optimal patient selection for this
therapy has become apriority for HF specialists and electrophysiologists. Cardiac imagingmodalities have
attempted to fulfill this need to improve patient selection by identifying mechanical dyssynchrony.
Although early echocardiographic studies reported promising results, more recent larger scale studies
have curtailed this enthusiasm, with a lack of established selection criteria for CRT in the current practice
guidelines. This reviewsummarizes theevidence todateand thepotential roleof imagingmodalities in the
selection and care of patients with HF referred for CRT. (J Am Coll Cardiol Img 2012;5:93–110) © 2012 by
the American College of Cardiology FoundationA
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he emergence of cardiac resynchronization
therapy (CRT) has provided cardiac caregivers
with a novel therapeutic option for patients
with refractory heart failure (HF). Large,
rospective clinical studies have demonstrated that
RT can provide significant improvement of both
ardiac mortality and morbidity (Table 1 [1–6]).
owever, up to 30% to 40% of patients do not
espond to CRT (1,2). CRT is invasive and carries
onsiderable costs related to implantation, serial device
onitoring, and requirement for multiple device ex-
hanges over a patient’s lifetime. The recently pub-
ished Resynchronization/Defibrillation for Ambula-
ory Heart Failure Trial found the incidence of
erious complications in the CRT-defibrillator arm,
uch as ventricular perforation or device-related
nfection, to be 13%, which was considerably higher
han in the implantable cardioverter-defibrillator
rm (7). Furthermore, recent clinical trials have
ound that even patients with mildly symptomatic
F receive mortality benefit with CRT (7,8)
Table 2 [6 –10]).
Cumulatively, these factors underscore a need for
mproved patient selection of this novel therapy to
chieve optimal therapeutic cost-effectiveness. Cur-
ent evidence indicates that cardiac imaging can
dentify and quantify the severity of mechanical
yssynchrony in patients beyond the presence of a
idened QRS complex on electrocardiography.lthough novel echocardiographic parameters were
eported to be promising in detecting mechanical
yssynchrony in single-center studies, such enthu-
iasm has been curbed by the negative results from
he recent prospective multicenter PROSPECT
Predictors of Response to Cardiac Resynchroniza-
ion Therapy) study. We anticipate that new echo-
ardiographic parameters will continue to emerge.
owever, novel imaging modalities, such as cardiac
agnetic resonance (CMR) can assess mechanical
yssynchrony differently from echocardiography
rom a technical perspective. CMR can also provide
he location of myocardial scar and coronary venous
natomy, which influence the likelihood for success
f CRT. In this report, we aim to review the
vidence in assessing mechanical dyssynchrony by
arious noninvasive imaging modalities and their
linical relevance.
Mechanism
The main rationale for CRT stems from resynchro-
nization of left ventricular (LV) contraction. Dys-
synchronous contraction of the left ventricle over
time may contribute to progressive negative remod-
eling and worsen patient symptoms and has been
associated with increased mortality and adverse
cardiovascular outcomes.
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95Patients with a left bundle branch block can have
atrioventricular, interventricular, and intraventricu-
lar dyssynchrony, each with respective adverse ram-
ifications on ventricular function. Interventricular
dyssynchrony results from septal depolarization
from the right ventricular bundle, as opposed to
physiologic left-sided activation, leading to asyn-
chronous right and LV contraction. Intraventricular
dyssynchrony within the left ventricle itself results
from septal and anteroseptal activation before the
lateral and inferolateral segments, resulting in re-
gional load disparities that can produce increased
wall tension. Discoordinated papillary muscle acti-
vation during systole leads to abnormal mitral valve
closure, with the development or worsening of
pre-existing mitral regurgitation (11).
CRT may confer benefits by coordinating right
ventricular and LV contraction, synchronizing the
LV segments, prolonging the diastolic filling period
with improvements of both coronary and LV filling,
and restoring atrioventricular synchrony. The Car-
diac Resynchronization–Heart Failure trial revealed
that CRT can provide up to a 30% improvement in
stroke volume and a significant reduction in mitral
regurgitation within 3 months of initiating therapy
(3). These beneficial effects on cardiac hemody-
namic parameters are associated with reduced myo-
cardial energy cost and may indirectly attenuate
maladaptive neurohormonal activation and auto-
nomic dysfunction. Recent studies have indicated
that correction of intraventricular dyssynchrony,
compared with interventricular dyssynchrony, plays
a more significant role in the efficacy of CRT (12).
Beyond the Electrocardiogram
Electrocardiography has numerous limitations for
identifying patients suitable for CRT. The thresh-
old criteria of a QRS duration of 120 ms was not
derived from prospective evaluation but rather from
inclusion criteria of landmark clinical trials (1,3,4).
In fact, the mean and median values of QRS
durations of patients enrolled in the largest CRT
trials were substantially higher than 120 ms (rang-
ing from 155 to 160 ms) (Table 1). Echocardio-
graphic studies have revealed a significant discor-
dance between electrical and mechanical delay, with
up to 30% of patients with QRS durations150 ms
and 50% of those with QRS durations 120 ms
demonstrating no evidence of septal to lateral dys-
synchrony (13). The QRS pattern may also further
complicate patient selection. More than 73% of
patients in the CRT arm of the Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
had interventricular conduction delays with left
bundle branch block patterns (7). Whether pa-
tients with right bundle branch block or nonspe-
cific interventricular conduction delays would
derive the same benefit from CRT remains un-
clear. Retrospective examination of landmark
CRT trials demonstrated no benefit of CRT in
patients with right bundle branch block for any
hard clinical end point (14).
Echocardiographic data suggest that up to 30%
to 50% of patients with symptomatic HF with
compromised LV ejection fractions (LVEFs) and
narrow QRS complexes (120 ms) have evidence
of mechanical dyssynchrony (15). The utility of
CRT in this patient population was eval-
uated in the Cardiac Resynchronization
Therapy in Patients With Heart Failure
and Narrow QRS study, which included
patients with QRS durations  130 ms
nd echocardiographic evidence of me-
hanical dyssynchrony. The study demon-
trated no difference for the primary end
oint of peak oxygen uptake at 6 months
ut found improvement in functional class
16). Although other studies also failed to
emonstrate any difference in secondary
utcome measures, such as LVEF, no
tudy to date has evaluated hard clinical
nd points in this population (Table 3
17–19]).
These data underscore the importance
f other diagnostic modalities that may
ore precisely identify potential respond-
rs of CRT, including patients who not
eet current clinical selection criteria.
Echocardiography
Over the past decade, echocardiography has
emerged as a potentially useful tool to assess me-
chanical dyssynchrony. There are numerous advan-
tages of echocardiography, including noninvasive-
ness, portability, and widespread availability.
Numerous echocardiographic techniques have been
devised to assess for dyssynchrony, including M
mode, pulsed-wave Doppler imaging, tissue Dopp-
ler imaging (TDI), speckle tracking, and real-time
3-dimensional (RT3D) imaging (Tables 3 and 4
[12,20–38]).
Interventricular dyssynchrony could be identified
by traditional 2-dimensional echocardiographic pa-
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Table 1. Landmark CRT Trials
Study n Inclusion Criteria QRS (ms) Design Blinding Control Intervention
Follow-Up
(months) Primary End Point Results
MIRACLE (4) 453 NYHA functional class III
or IV, LVEF  35%,
LVEDD  55 mm, SR
130 Parallel Double
blind
CRT-Off CRT-On 6 6MWD, NYHA functional
class, MLHFQ score
1 6MWD (p  0.005), improved
NYHA functional class (p  0.001),
2 MLHFQ score (p  0.001)
MIRACLE-ICD (5) 369 NYHA functional class III
or IV, LVEF  35%,
LVEDD  55 mm,
ICD indicated, SR
130 Parallel Double
blind
CRT-D
(CRT-Off)
CRT-D (CRT-On) 6 Peak VO2, NYHA
class, MLHFQ score
1 6MWD (p  0.36), improved
NYHA functional class (p  0.007),
2 MLHFQ score (p  0.02)
Contak CD (6) 490 NYHA functional class
II–IV, LVEF  35%,
ICD indicated, SR
120 Parallel Double
blind
CRT-D
(CRT-Off)
CRT-D (CRT-On) 6 Composite: all-cause mortality,
HF hospitalization, VT/VF
requiring intervention
RRR 15% (p  0.35)
COMPANION (1) 1,520 NYHA functional class III
or IV, LVEF  35%,
LVEDD  60 mm, SR
120 1:2:2 — Medical
therapy
CRT-P, CRT-D 16.2 (median) All-cause mortality or
hospitalization
CRT-P HR: 0.81 (95% CI: 0.69–0.96;
p  0.014); CRT-D HR: 0.80
(95% CI: 0.68–0.95; p  0.010)
CARE-HF (3) 813 NYHA functional
class III or IV, LVEF 
35%, SR
150, 120–150 
echocardiographic
dyssynchrony
Parallel — Medical
therapy
CRT-P 29.4 (mean) All-cause mortality or CV
hospitalization
HR: 0.63 (95% CI: 0.51–0.77;
p  0.001)
CARE-HF
Extended (2)
37.4 All-cause mortality HR: 0.60 (95% CI: 0.47–0.77;
p  0.0001)
CARE-HF  Cardiac Resynchronization–Heart Failure; CI  conﬁdence interval; COMPANION  Comparison of Medical Therapy, Pacing, and Deﬁbrillation in Heart Failure; CRT  cardiac resynchronization therapy; CRT-D  cardiac resynchronization
therapy with deﬁbrillator; CRT-P  cardiac resynchronization therapy only; HF  heart failure; HR  hazard ratio; ICD  implantable cardioverter-deﬁbrillator; LVEDD  left ventricular end-diastolic dimension; LVEF  left ventricular ejection fraction;
MIRACLEMulticenter InSync Randomized Clinical Evaluation; MIRACLE-ICDMulticenter InSync ICD Randomized Clinical Evaluation; MLHFQMinnesota Living With Heart Failure Questionnaire; NYHA New York Heart Association; RRR relative
risk ratio; 6MWD  6-minute walk distance; SR  sinus rhythm; VF  ventricular ﬁbrillation; VO2  oxygen consumption; VT  ventricular tachycardia; 1  increased; 2  decreased.
Table 2. CRT Trials in Mildly Symptomatic Heart Failure (NYHA Functional Classes I and II)
Study n Inclusion Criteria Design Blinding Control Intervention Follow-Up Primary End Point Response
Contak CD (6) SeeTable1
MIRACLE-ICD 2 (9) 186 NYHA functional class
II, LVEF  35%, QRS
 130 ms, LVEDD 
55 mm, ICD
indicated, SR
Parallel Double blind CRT-D (CRT-Off) CRT-D (CRT-On) 6 months Change in peak VO2 1 Peak VO2 (p  0.87)
REVERSE (10) 610 NYHA functional class I
or II, QRS  120 ms,
LVEF  40%, LVEDD
 55 mm, SR
Parallel Double blind CRT-D (CRT-Off) CRT-D (CRT-On) 24 months HF clinical composite
score (worsening)
19% vs. 34% (p  0.01)
MADIT-CRT (8) 1,820 NYHA functional class I
or II, LVEF  30%,
QRS  130 ms, SR
3:2 Single blind ICD CRT-D 2.4 yr (mean) All-cause mortality or
nonfatal HF
HR: 0.66 (95% CI: 0.52–
0.84; p  0.001)
RAFT (7) 1,798 NYHA functional class II
(80%) or III (20%),
LVEF  30%, QRS 
120 ms
Parallel Double blind CRT-D (CRT-Off) CRT-D (CRT-On) 40 months (mean) All-cause mortality or
HF hospitalization
HR: 0.75 (95% CI: 0.64–
0.87; p  0.001)
MADIT-CRT  Multicenter Automatic Deﬁbrillator Implantation Trial With Cardiac Resynchronization Therapy; RAFT  Resynchronization/Deﬁbrillation for Ambulatory Heart Failure Trial; REVERSE  Resynchronization Reverses Remodeling in Systolic
Left Ventricular Dysfunction; other abbreviations as in Table 1.
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97marily assessed by quantitative echocardiographic
methods. The difference of the pre-systolic period,
measured from the onset of the QRS complex on
the electrocardiogram to the initiation of Doppler
flow in the pulmonary artery and the aorta, respec-
tively, may be used to measure interventricular
dyssynchrony. A difference of the pre-systolic pe-
riod of 49 ms, as a marker of interventricular
dyssynchrony, has been shown in retrospective analy-
sis of the CARE-HF (Cardiac Resynchronization–
Heart Failure) trial to correlate with event-free sur-
vival (20), as well as an independent predictor of
response in the SCART (Selection of Candidates for
Cardiac Resynchronization Therapy) trial (21). An-
other method of assessing interventricular dyssyn-
chrony uses pulsed-wave tissue Doppler to measure
the difference in time to contraction of the right
ventricle and the lateral wall of the left ventricle
visualized with the apical 4-chamber view. This pa-
rameter, however, has not shown any association with
CRT outcomes. Other pulsed-wave Doppler tech-
niques for dyssynchrony assessment include quantita-
tion of the physiological intervals of the cardiac cycle,
such as filling and isovolumetric contraction times.
M-mode echocardiography. M-mode echocardiog-
aphy can assess septal to posterior wall motion
elay obtained from the short-axis parasternal view
f the left ventricle (Fig. 1). More recent color
-mode imaging makes use of TDI (see the
ollowing discussion) for quantification of septal to
osterior wall motion delay (Fig. 2). Although
-mode echocardiography provides extremely high
emporal resolution, there are several limitations,
ncluding the depth of ultrasound penetration, an-
ulation issues across acoustic windows of the chest
all, and the requirement for myocardial walls to be
s perpendicular to the transducer as possible.
ssessment by M-mode imaging is especially chal-
enging if the myocardial segments are akinetic
ecause of prior myocardial infarction or scar, as
nward excursion cannot be readily identified rela-
ive to the opposing wall. Additionally, this method
f interrogation cannot differentiate between pas-
ive and active motion, which is a crucial aspect of
echanical dyssynchrony assessment. Early studies
emonstrated a correlation of septal to posterior
all motion delay  130 ms with reverse remodel-
ng (22), but recent studies have failed to demon-
trate any association of septal to posterior wall
otion delay with clinical outcomes after CRT
mplantation (23).
TDI. TDI may be used to assess tissue velocity or
strain by myocardial deformation. TDI by pulsed-T Y
E R ES W
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98Table 4. Echocardiographic Dyssynchrony Assessment
Method Threshold (ms) Studies Limitations Attributes
Pulsed-wave Doppler
IVMD 44 Achilli et al. (21): 1 LVEF  5% 
NYHA functional class
Requires stable heart rate intervals
Affected by RV function
Highly reproducible
LV ﬁlling time/R-R
interval
40% Requires nearly parallel
interrogation of MV inﬂow
Highly reproducible
M-mode echocardiography
SPWD 130 Pitzalis et al. (22): 1 LVEF  5%
Marcus et al. (23): not predictive
Difﬁcult in patients with wall
motion abnormalities (prior MI
or scar)
Cannot differentiate active 
passive motion
High temporal resolution
Highly reproducible
Easily trained
No specialized software required
TDI: pulsed wave
LVDYS 102 Penicka et al. (24): 1 LVEF  25%
Achilli et al. (21): not predictive
Cannot differentiate active 
passive motion
Technically challenging
Requires optimal image quality
Angle dependent
Cannot assess multiple segments
in 1 view
High temporal resolution
No special probe required
TPSV-SD (6 segments) 31.3 Jansen et al. (31): 2 LVESV  15%
TOSV-DF 60 Soliman et al. (32): not predictive
Color TDI
TPSV-DF (2 segments) 60–65 Bax et al. (12): 2 LVESV  15% Cannot differentiate active 
passive motion
Requires technical expertise
High temporal resolution
Multiple segments may be assessed
in 1 view
TPSV-DF (6 segments) 105–110 Knebel et al. (20): 2 LVESV  15%
SPWD 130 Bleeker et al. (33): 2 LVESV  10%
Yu index 31.4–33 Yu et al. (25,26): 2 LVESV  15%
Gorcsan et al. (34):
death/transplantation/
LVAD implantation
TSI
TPSV-DF 65 Van de Veire et al. (35): 2 LVESV
 15%  NYHA, 6MWD
Yu index 34.4 Yu et al. (36): 2 LVESV  15%
TDI strain
TPSS-DF (radial) 130 Dohi et al. (37): 1 SV  15% Highly angle dependent
Requires technical expertise
Requires optimal image quality
May differentiate between passive 
active motion
High temporal resolution
TPSS-SD (12 segments) 60 Mele et al. (38): 2 LVESV  15%
Speckle tracking
SPWD (radial) 130 Suffoletto et al. (27): 1 SV  15%
Gorcsan et al. (34):
death/transplantation/LVAD
implantation
STAR study (28):
death/transplantation/LVAD
implantation
Delgado et al. (29): mortality  HF
hospitalization
Requires optimal image quality
with high frame rate
Requires technical expertise
Speckles must remain in imaging
plane
Angle independent
May perform ofﬂine analysis on
routine images
May assess radial, longitudinal, and
circumferential strain
RT3D echocardiography
LVDYS index
(16 segments)
5.6% Marsan et al. (30):2 LVESV  15% Slower frame rates
Requires optimal image quality
Inability to differentiate active 
passive motion
Lower temporal  spatial
resolution
Requires regular rhythm
Requires special ultrasound probe
More complete 3D analysis
Angle independent
Assess radial, longitudinal, and
circumferential contraction
Accurate LVEF assessment
DF  difference; IVMD  interventricular mechanical delay; LV  left ventricular; LVAD  left ventricular assist device; LVDYS  left ventricular dyssynchrony; LVEF  left ventricular ejection
fraction; MV  mitral valve; NYHA  New York Heart Association; RT3D  real-time 3-dimensional; RV  right ventricular; SPWD  septal to posterior wall delay; STAR  Speckle Tracking and
Resynchronization; 3D  3-dimensional; TPSS  time to peak systolic strain; TPSV  time to peak systolic velocity; TSI  tissue synchronization imaging; other abbreviations as in Tables 1 and 3.
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99wave Doppler allows the assessment of longitudinal
myocardial tissue velocity relative to the ultrasound
transducer and has been the most investigated
echocardiographic modality for dyssynchrony eval-
uation. Indexes of dyssynchrony may be generated
from differences in the peak velocity, time to peak
systolic velocity, or time to onset of peak systolic
velocity of the LV walls as assessed in either single
or multiple views (2, 4, or 12 segments). Although
TDI also enjoys high temporal resolution similar to
that of M-mode echocardiography, limitations in-
clude the requirement for interrogation of Doppler
velocity data perpendicular to the ultrasound beam,
limited tissue penetration, the need for adequate
acoustic windows, and the inability to simultane-
ously assess more than 2 LV segments at once.
Because of the nature of assessment relative to the
ultrasound transducer, measurements are prone to
error related to tethering of myocardium to sur-
rounding tissues and translational motion of the
heart. Pulsed-wave TDI must be performed online,
with preclusion of further offline analysis. Numer-
ous studies have evaluated TDI by pulsed-wave
Doppler indexes of dyssynchrony for response to
CRT, some demonstrating improvements in echo-
cardiographic parameters (24) and others finding no
association with reverse remodeling or clinical out-
comes (21).
Color-coded TDI (Fig. 3) and color tissue syn-
chronization imaging provide expansion over
pulsed-wave Doppler for regional LV assessment by
allowing the simultaneous interrogation of time to
peak velocity for multiple myocardial segments in 1
view (13). Tissue synchronization imaging involves
the identification of regional mechanical delay by
overlaying color-coded temporal velocity data onto
2-dimensional or 3-dimensional images of the left
ventricle. This assessment requires proficiency with
involved post-processing software, as well as opti-
mal image quality during acquisition of the study.
Indexes that incorporate the standard deviation of
time to peak systolic velocity for multiple myocar-
dial segments have been proposed and shown to
have higher correlation with reverse remodeling
over standard color TDI parameters (25). Experi-
enced centers have reported low intraobserver and
interobserver variability for color TDI parameters of
dyssynchrony (25), whereas other studies, including
the PROSPECT trial, have found poor reproduc-
ibility (39). Studies evaluating color TDI have
demonstrated an association with improved LVEF
and reverse remodeling (25). Other parameters may
be derived from tissue velocity data, such as myo- scardial displacement, strain, and strain rate, but
these measures have been shown to be inferior in
comparison with TDI velocity (26).
Strain and strain rate. Myocardial strain, the per-
entage change of myocardial length from end-
iastole to end-systole, and its time derivative,
train rate, may be assessed using TDI (see the
revious discussion) or speckle tracking. Speckle
racking involves a post-processing computer algo-
ithm that applies specific acoustic markers to the
yocardium, termed “speckles,” to conventional
-dimensional or 3-dimensional digital echocardio-
raphic images (Fig. 4). Movements of these mark-
rs are tracked during the cardiac cycle, frame by
rame, to determine regional myocardial strain.
train is advantageous over the assessment of mo-
ion because it measures myocardial deformation
nd may therefore differentiate between passive
ranslational motion of the myocardium and active
Figure 1. Interventricular Mechanical Delay by Pulsed Doppler
(Top) Time from onset of right ventricular (RV) ejection (arrows), ob
from the parasternal short-axis window. (Bottom) Time from onset
ventricular (LV) ejection (arrows), obtained from the apical 5-chamb
cardiographic view. Reprinted, with permission, from Gorcsan J III. E
diographic assessment of ventricular dyssynchrony. Curr Heart Fail
2008;5:31–7.tained
of left
er echo-
chocar-
Repystolic contraction.
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100Despite lower temporal resolution, speckle track-
ing has numerous advantages over TDI, including
the ability to assess circumferential and radial strain
in addition to longitudinal strain, relatively angle
independent image acquisition, and significantly
faster post-processing and image analysis. Despite
these attributes, speckle tracking is limited by infe-
rior temporal resolution compared with TDI, and
similar to TDI, it requires technical expertise with
post-processing software and is highly dependent
on image quality. Single-center studies that evalu-
ated delays to peak radial strain with speckle track-
ing have reported a significant association with
response to CRT (2,27). The prospective, multi-
center STAR (Speckle Tracking and Resynchroni-
zation) trial evaluated speckle-tracking assessment
of strain in 132 patients referred for conventional
CRT indications. Both radial and longitudinal
strain were associated with favorable LVEF re-
sponse and long-term freedom from death, LV
assist device implantation, or transplantation over
3.5 years of follow-up (28). A more recent study of
397 patients with ischemic cardiomyopathy eval-
uated with speckle tracking before CRT found
that discordant LV lead position and myocardial
scar in the region of the LV pacing lead were
independent determinants of all-cause mortality
and HF hospitalization, while the extent of
baseline LV radial dyssynchrony was associated
Figure 2. Color M-Mode Echocardiography
(A) Conventional M-mode echocardiography. Evaluating earliest act
infarction. (B) M-mode echocardiography with color-coded tissue ve
change from blue to red (arrows demonstrate change in color den
heads for the posterior wall [PW]). LV  left ventricular; SPWMD 
from Anderson LJ, Miyazaki C, Sutherland GR, Oh JK. Patient selecti
resynchronization therapy. Circulation 2008;117:2009–23.with improved survival (29). nRT3D echocardiography. RT3D echocardiography
an simultaneously assess 3-dimensional ventricular
olumes and systolic contraction of all LV segments
uring the cardiac cycle (Fig. 5). Dyssynchrony
ndexes may be generated by calculating the stan-
ard deviation of the timing of inward systolic
xcursion of the various LV segments. The acquired
ata may be post-processed to generate color maps,
hich can localize regional dyssynchrony in real
ime as well as in 3 dimensions. This provides
dvantages over 2-dimensional methods, including
ngle-independent assessment of strain in all direc-
ions during the cardiac cycle. Additional parame-
ers for LV assessment, including function, and
olumes may be quantified with high accuracy
ithout the need for any geometric assumptions.
espite these multiple attributes, a number of
hallenges presently exist for RT3D echocardiogra-
hy. Data acquisition is more challenging than with
-dimensional methods, with a high degree of
eliance on excellent acoustic windows and stable
ardiac rhythms. RT3D imaging has limited temporal
nd spatial resolution compared with 2-dimensional
ethods; requires time-consuming, technically chal-
enging post-processing; and suffers from limited
eproducibility of time-volume curves for akinetic
egments. One study of 60 consecutive patients
emonstrated correlation of RT3D findings with
V reverse remodeling (30). Presently, there has
ion is difﬁcult because of hypokinesis and wall thinning from prior
ty. Activation may be more easily assessed visually as a color
g myocardial contraction for the ventricular septum [VS], arrow-
tal to posterior wall motion delay. Reprinted, with permission,
nd echocardiographic assessment of dyssynchrony in cardiacivat
loci
otin
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on aot been any clinical study evaluating the role of
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101RT3D echocardiography in guiding CRT or its
association with cardiac outcomes.
The PROSPECT trial. Despite the development of
umerous echocardiographic methods to assess dys-
ynchrony in the past decade, many of the studies
valuating these techniques have fallen under scru-
iny for reasons including single-center experience
ith limited study populations, absence of control
rms, and controversial end points with surrogate
arkers of outcomes. Furthermore, most studies
ncluded largely retrospective data from echocardio-
raphic registries, different threshold cutoffs for the
ame technique, short follow-up, and lack of ran-
omization, blinding, or reporting of intraobserver
nd interobserver variability. Numerous studies
ave used the surrogate outcome measure of reverse
emodeling, defined as a reduction in LV end-
ystolic volume of 10% to 15%, as opposed to
ard clinical end points. Although some studies
ave correlated reverse remodeling to clinical out-
omes, other studies have demonstrated clinical
esponse in patients without reverse remodeling
40). Post hoc analysis of the Cardiac Resynchro-
Figure 3. Color-Coded Tissue Velocity
(A) Color-coded tissue velocity data from 12 left ventricular segmen
(middle) apical 3-chamber view, and (right) apical 2-chamber view.
the various segments. (B) The same study after cardiac resynchroni
tion. AVC  aortic valve closure; AVO  aortic valve opening. Repr
Oh JK. Patient selection and echocardiographic assessment of dyssy
2008;117:2009–23.ization–Heart Failure study failed to demonstrate on independent association of reverse remodeling at
months after CRT with mortality (2). Another
oncern includes different threshold cutoffs among
ifferent studies for the same echocardiographic
arameter, some of which have also been shown in
symptomatic, normal subjects (41). Finally, many
ingle-center studies have not reported 95% confi-
ence intervals, suggesting wide boundaries that
ay limit clinical utility.
To obtain a more comprehensive evaluation of echo-
ardiographic parameters for dyssynchrony, a large,
onrandomized, multicenter trial (PROSPECT) was
erformed in 498 patients with HF with standard
ndications for CRT (39). Twelve different echo-
ardiographic measures of dyssynchrony were eval-
ated. The study included blinded analysis per-
ormed by international core laboratories for the
utcome measures of clinical composite score and
V reverse remodeling. None of the 12 echocar-
iographic methods proved to be sensitive or spe-
ific enough to be clinically useful for predicting
esponse to CRT. The PROSPECT study demon-
trated a high variance of TDI measurements
n a patient with dyssynchrony. (Left) Apical 4-chamber view,
ows mark differences in time to peak velocity during systole for
n therapy, with reduction in the disparity of time to peak activa-
, with permission, from Anderson LJ, Miyazaki C, Sutherland GR,
rony in cardiac resynchronization therapy. Circulationts i
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nchwing to a number of factors inherent to the
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102determination of these values, including operator
dependence, angle of interrogation, and acoustic
windows. Even the same patient with repeated
studies over time had significant variation in the
echocardiographic dyssynchrony parameters. Al-
though the PROSPECT study has been criticized for
a number of design issues, at the time of the trial,
many of the echocardiographic parameters being eval-
uated were still novel, and most centers did not have
extensive experience with their evaluation. More re-
cent analysis of the PROSPECT study revealed an
association between the extent of LV dyssynchrony at
baseline and the extent of reverse remodeling at
6-month follow-up (40). Whether the results of the
PROSPECT trial are generalizable to today’s stan-
dard of dyssynchrony assessment remains in conten-
tion.
Echocardiography may also play a significant role in
serial follow-up of patients for optimization of CRT.
In addition to continued noninvasive assessment of
remodeling and ventricular function, optimization of
pacemaker atrioventricular delay and right ventricu-
lar–LV lead intervals may avoid residual dyssynchrony
after CRT implantation. Despite early promising data
suggesting benefit, the multicenter, prospective
SMART-AV (SmartDelay Determined AV Optimi-
zation) trial demonstrated no difference in the primary
end point of HF-related adverse events at 6 months
(42). A second study, which compared an electronic
algorithm to echocardiographic optimization of CRT,
Figure 4. Two-Dimensional Speckle Tracking
Apical view of the left ventricle demonstrating 2-dimensional speck
ference between peak strain of the septal segments and the poster
with permission, from Delgado V, Bax JJ. Assessment of systolic dys
Circulation 2011;123:640–55.also found no difference for HF composite score in Cmore than 1,600 patients (43). Although proponents
of echocardiographic optimization argue that these
studies did not target nonresponders, who may have
the greatest potential for benefit, further evaluation is
clearly required.
Magnetic Resonance Imaging
Recently, CMR has gained increasing attention for
dyssynchrony assessment because of its high tissue
and spatial contrast, coupled with highly accurate
and reproducible assessment of LV volume and
functional indexes. CMR techniques to assess dys-
synchrony are rapidly expanding and are presently
under evaluation in a number of studies.
MRI dyssynchrony. The advantages of contrast me-
ium–enhanced CMR include high spatial resolu-
ion and tissue characterization, in addition to
ighly accurate quantification of chamber size and
entricular function and 3-dimensional assessment
f myocardial strain. Compared with echocardiog-
aphy, CMR has high reproducibility owing largely
o tomographic imaging with less operator depen-
ency. Disadvantages of CMR include long acqui-
ition times, implanted cardiac devices as magnetic
esonance hazards, and complex post-processing
echniques. In recent years, newer methods have
mproved the efficiency and standardization of
ost-processing.
The most basic assessment of dyssynchrony by
acking for radial strain assessment of dyssynchrony. The time dif-
eral segments are shown. AVC  aortic valve closure. Reprinted,
hrony for cardiac resynchronization therapy is clinically useful.le tr
olat
syncMR is achieved with cine MRI, which produces a
ulat
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103continuous series of oblique, short-axis slices from
the ventricular apex to the base. This allows accu-
rate volumetric assessment of chamber sizes and
ventricular function indexes, such as stroke volume
and LVEF. Interventricular and intraventricular
dyssynchrony may be assessed qualitatively or quan-
titatively with software that tracks the myocardium
during the cardiac cycle (44). Although cine MRI is
acquired routinely, it is not particularly optimized
for evaluation of regional dyssynchrony. More di-
rect methods have been developed that provide
more accurate and direct assessment of intramyo-
cardial deformation, including myocardial tagging,
strain-encoded MRI (SENC), phase-contrast
MRI, and displacement encoding with stimulated
echoes (DENSE), amongst others.
Myocardial tagging. Myocardial tagging is analo-
gous to speckle tracking by echocardiography but
with higher spatial resolution and reproducibility.
Myocardial tagging is achieved by creating dark
tagged lines or a grid over the myocardium through
saturation of the magnetization in planes perpen-
dicular to the imaged slice (Fig. 6). Tag lines enable
Figure 5. Three-Dimensional Echocardiographic Evaluation of D
(A) Systolic dyssynchrony index used to evaluate left ventricular (LV
(stdev) of time to minimal systolic regional volume of the 17-segme
to contraction of the left ventricle. The green regions represent ear
latest to contract. (C) Three-dimensional speckle tracking for assess
(radial strain is shown). A polar map denoting relative regional dela
synchrony. ant  anterior; ECG  electrocardiogram; inf  inferior;
sept  septal; TSI  tissue synchronization index. Reprinted, with p
chrony for cardiac resynchronization therapy is clinically useful. Circan accurate analysis of myocardial motion and dis-placement, which has been shown to be a robust
method for assessment of both intraventricular and
interventricular dyssynchrony (45). Newer methods of
tagging, such as spatial modulation of magnetization,
have resulted in shorter acquisition times and im-
proved image quality of the myocardial tags (46).
Most echocardiographic techniques, apart from
speckle tracking and RT3D imaging, are limited to
the assessment of longitudinal strain. Data from
animal models, in addition to more recent echocar-
diographic studies using speckle tracking, suggest
that circumferential and radial strain more accu-
rately predict response to CRT (27). Although
2-dimensional myocardial tagging can assess both
circumferential and radial strain, the ability to track
myocardial motion in 3 dimensions by inclusion of
tagged long-axis cine imaging is an attractive ex-
tension that would also permit the assessment of
longitudinal strain (47). Recently, 3-dimensional
tagging with CMR has become more straightfor-
ward to analyze with the use of a post-processing
technique termed harmonic phase imaging. The
significant advantage of harmonic phase imaging
nchrony
echanical dyssynchrony calculated from the standard deviation
V model. (B) Time dispersion map relating relative regional delay
myocardial contraction, while orange and red regions are the
t of strain. The time dispersion to peak strain may be calculated
lue earliest, yellow latest) also provides visual assessment of dys-
 lateral; max  maximal; post  posterior; seg  segments;
ission, from Delgado V, Bax JJ. Assessment of systolic dyssyn-
ion 2011;123:640–55.yssy
) m
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ermrelates to almost observer-independent estimation
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104of myocardial strains that permits quick and accu-
rate post-processing of tagged cine images. Data
from myocardial tagging may be used to produce
myocardial strain-versus-time plots for the various
ventricular walls that may be displayed and read
similarly to a 12-lead electrocardiogram (48).
By directly tracking intramyocardial motion
across the cardiac cycle, myocardial tagging may
provide more specific assessment of myocardial
deformation than TDI by differentiating regional
strain abnormalities due to intrinsic abnormalities
of myocardial contraction from passive tethering.
TDI is more susceptible to errors from rotational
motion of the heart and passive tethering as a result
of determining myocardial velocity with respect to
the mitral valve annulus or ultrasound transducer as
opposed to the myocardium itself. Comparison
with TDI has demonstrated higher specificity for
dyssynchrony by myocardial tagging (17). Circum-
ferential strain as assessed by tagging has also
shown high correlation with LV volume curves
assessed by RT3D echocardiography (49). A fur-
ther advantage of myocardial tagging relates to the
Figure 6. Myocardial Tagging by Cardiac Magnetic Resonance I
(A) Progressive deformation of the gird over the course of the card
are contracting relatively late during systole. (B) Volumetric change
(C) Polar map illustrating the time course for contraction of the my
Reprinted, with permission, from Abraham T, Kass D, Tonti G, et al.
2009;2:486–97.derivation of circumferential strain through assess-ment of the entire myocardium, as opposed to using
specific myocardial segments. True 3-dimensional
assessment for regional dyssynchrony, in addition to
determination of the extent of dyssynchronous
myocardium, may be performed to differentiate
those patients with diffusely dyssynchronous seg-
ments from those with clustered dyssynchronous
segments within a particular wall, who may have a
very different response to CRT. Use of a dyssyn-
chrony index derived from myocardial tagging with
CMR in a single-center study was highly predictive
of improved functional class after CRT (50). Ac-
curacy was further improved by the addition of late
gadolinium enhancement imaging for the identifi-
cation of myocardial scar.
SENC. SENC is another method for the assessment
of dyssynchrony that involves using sinusoidal
“tagged” surfaces that modulate longitudinal mag-
netization perpendicular to the imaging plane.
Myocardial deformation during the cardiac cycle
alters the local tag frequency in both the longitudi-
nal and circumferential directions, which may be
automatically detected and represented by a color
ing
ycle. This allows visual estimation of regions of myocardium that
he myocardial segments over the course of the cardiac cycle.
dial segments of the left ventricle (LV). RV  right ventricle.
ging cardiac resynchronization therapy. J Am Coll Cardiol Imgmag
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105reduces any required post-processing, as with myo-
cardial tagging, and has further advantages of high
temporal and spatial resolution, in addition to
extremely short acquisition time. SENC may be
used to simultaneously assess regional strain of the
right ventricle in addition to the left ventricle.
SENC is limited by a requirement for sinusoidal
magnetization modulation perpendicular to the im-
age plane, which effectively precludes the assess-
ment of radial strains. Both myocardial viability and
regional strain may be simultaneously acquired with
composite SENC, correlating regional strain with
the extent of scar, which is highly desirable for
CRT assessment (52). SENC and a method of
performing fast SENC with an acquisition duration
of only 1 heartbeat have shown excellent correlation
with myocardial tagging (53). However, to date, no
clinical outcome studies for CRT have been per-
formed evaluating SENC or any of its derivatives.
Phase-contrast MRI. Phase-contrast velocity mapping
uses the shift in phase of the myocardium between 2
opposing pulse gradients, which is proportional to the
velocity of the myocardium. A color or gray scale is
used to represent the magnitude and direction of
tissue displacement in 3 dimensions. This method
provides high temporal (2 ms) and spatial resolution
and does not require the use of “tags” or segmentation
of the myocardium. This is the CMR technique most
similar in terms of imaging concept to TDI and has
shown high correlation with the echocardiographic
method (54). To date, there is a relative paucity of
data assessing clinical response to CRT using phase-
contrast MRI.
DENSE. DENSE encodes positional information
into the phase of each image pixel. Therefore, the
spatial resolution of DENSE is limited to only a
single pixel (55). Using DENSE imaging, myocar-
dial deformation may be tracked in 3 dimensions
over the course of the cardiac cycle and is amenable
to automated post-processing. DENSE imaging
has been shown to have high correlation with
myocardial tagging for regional wall motion abnor-
malities (56). However, similar to other CMR
techniques, DENSE imaging has not been studied
in relation to clinical response to CRT.
Presently, the above CMR methods provide a
wealth of 3-dimensional data over the entire cardiac
cycle. Future directions include a method of integrat-
ing this data into a simplified and standardized dys-
synchrony index that may be used to efficiently screen
and follow patients with CRT over time. One such
index proposed by Leclercq et al. (57) uses strain data
from the entire myocardium to derive a global dys-synchrony score graded from 0 (pure dyssynchrony) to
1 (pure synchrony). This index has been used both to
determine optimal LV lead placement (58) as well as
for predicting clinical response to CRT.
Late gadolinium enhancement. One particular attri-
ute of CMR is the potential to provide an inte-
rated assessment for CRT. CMR can delineate
hamber size and function with high accuracy,
ssess prognosis, determine myocardial perfusion,
nd help guide lead placement through assessment
f the extent and location of myocardial scar and
oronary venous anatomy, all in addition to dys-
ynchrony. This holistic evaluation may more
ccurately and cost-effectively screen patients for
RT. However, the relative contraindication of
erforming CMR in patients with a device pre-
Figure 7. Posterolateral Scar by Cardiac Magnetic
Resonance Imaging
(A,B) Late gadolinium enhancement images by cardiac magnetic
resonance imaging demonstrating dense posterolateral scar in
the left ventricle. Reprinted, with permission, from Bax JJ, Gorc-
san J III. Echocardiography and noninvasive imaging in cardiac
resynchronization therapy: results of the PROSPECT (Predictors
of Response to Cardiac Resynchronization Therapy) study in per-
spective. J Am Coll Cardiol 2009;53:1933–43.
w
r
d
a
(
w
r
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 , 2 0 1 2
J A N U A R Y 2 0 1 2 : 9 3 – 1 1 0
Heydari et al.
Imaging for Planning of Cardiac Resynchronization Therapy
106cludes using CMR to evaluate device therapy for
serial follow-up.
Multiple observational studies have suggested that
the extent of myocardial scar is predictive of response
to CRT (59–61). Furthermore, scar in the location of
LV lead placement may reduce the effectiveness of
CRT (60) (Fig. 7). One study of 40 patients with
ischemic cardiomyopathy found lower response rates
to CRT and no change in dyssynchrony for those with
posterolateral scar (14% vs. 81%, p 0.05) compared
ith those without (60). Another study of 23 patients
eported that a cutoff value of 15% total LV myocar-
ial scar provided sensitivity and specificity of 85%
nd 90%, respectively, for clinical response to CRT
59). Other studies have shown that pacing in a site
ith 50% scar transmurality was associated with
esponse to CRT (61).
Radionuclide Imaging
Similar to CMR, radionuclide imaging represents
an attractive option for the selection of CRT in
patients with HF because of its potential for com-
prehensive evaluation of LVEF and degree of myo-
Figure 8. GMPS Phase Polar Map and Phase Histogram
Gated myocardial perfusion single-photon emission computed tomogr
cardiac resynchronization therapy (CRT). The colored phase polar map
septum before CRT, which corrects after CRT. The phase histogram be
delayed contraction of the lateral wall compared with the septum. The
more synchronized contraction. Reprinted, with permission, from Frieh
heart failure: detecting coronary artery disease and guiding device therapycardial scar, in addition to mechanical dyssyn-
chrony. Abnormalities of resting perfusion assessed
by single-photon emission computed tomographic
imaging have been associated with reduced im-
provement of functional and ventricular parameters
after CRT (62). In addition to these parameters,
phase analysis imaging from routine gated myocar-
dial perfusion single-photon emission computed
tomography (GMPS) may be used for dyssyn-
chrony assessment (63). GMPS evaluates the pat-
tern of ventricular activation through determination
of regional LV counts during the cardiac cycle. An
increase in counts is believed to correlate with
regional LV wall thickening and may be used to
assess the pattern of systolic contraction. Data from
the entire myocardium are used to generate a phase
distribution map that may be displayed as a histo-
gram or polar map (Fig. 8).
Phase imaging analysis with GMPS for the
identification of dyssynchrony has been validated in
studies using TDI by echocardiography (63). The
degree of LV dyssynchrony as assessed by GMPS
was also shown to correlate with response to CRT
in a study of 42 patients with severe LV dysfunction
y (GMPS) phase polar map before (top left) and after (bottom left)
onstrates delayed contraction of the lateral wall compared with the
CRT (top right) demonstrates a wide bandwidth consistent with
ase histogram narrows after CRT (bottom right), consistent with
M, Soman P. Newer applications of nuclear cardiology in systolicaph
dem
fore
ph
ling
. Curr Heart Fail Rep 2011;8:106–12.
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107(64). A recent study evaluated the use of GMPS to
determine the site of latest LV activation for LV
lead placement and found a significantly higher
response rate for patients with GMPS-guided LV
lead placement, defined as a decrease of 15% in
LV end-systolic volume (65).
Another method of phase imaging analysis from
gated blood-pool ventriculography may also evalu-
ate mechanical dyssynchrony. This method was
evaluated in a study of 103 patients with idiopathic
dilated cardiomyopathy and was shown to be a
significant predictor of adverse clinical outcomes in
multivariate analysis (66). However, this technique
requires sophisticated post-processing to carefully
identify ventricular regions while excluding extra-
cardiac structures and remains largely investiga-
tional.
A number of limitations of nuclear dyssynchrony
assessment, including sophisticated post-processing
techniques, potentially hazardous radiation expo-
sure, and limited spatial resolution, have limited
more widespread use. Limited spatial resolution not
only affects dyssynchrony assessment but may also
lead to overestimation of scar and concomitant
underestimation of myocardial viability, particularly
in this patient population with dilated cardiomyop-
athies and thin myocardial walls. Finally, studies to
date evaluating GMPS have been small, single-
center experiences, which have mostly evaluated
secondary outcome measures.
Cardiac Computed Tomography
Mechanical dyssynchrony assessment by cardiac
computed tomography (CCT) has previously been
limited by poor temporal resolution. However, since
the advent of dual-source multidetector computed
tomography, both temporal and spatial resolution
have significantly improved, redefining the role of
CCT for the assessment of patients with HF.
CCT may be especially useful to help guide
endocardial LV lead placement for CRT. Apart
from prolonged procedure times with resultant
increased risk for periprocedural complications and
radiation exposure, inadequate LV lead position
may lead to poor response to CRT. Pre-procedural
use of CCT to characterize venous anatomy may
substantially aid in LV lead placement (Fig. 9). One
prospective, single-center study of 22 patients (9
with pre-procedural CCT and 13 without) reported
decreased procedural times, use of contrast media,
and radiation exposure (67).
Truong et al. (68) recently evaluated the utility of
CCT for dyssynchrony assessment in a study of 38patients with HF and normal controls. They de-
vised an index of dyssynchrony on the basis of the
standard deviation of time from the R-wave of the
electrocardiogram to maximal wall thickness as
assessed by CCT. Although they found a significant
difference for the dyssynchrony index in patients
with HF compared with the normal controls, com-
parison with echocardiographic measures of dyssyn-
chrony demonstrated only a moderate correlation
(r  0.65, p  0.012). LV structure and function
assessment by CCT has also improved, although
CCT has not performed as well in patients with LV
dysfunction, with a tendency to overestimate LVEF
(69). The use of dual-source multidetector com-
puted tomography may identify and quantitate scar
burden within the myocardium. This technique has
been validated against CMR, although contrast-to-
noise ratio is inferior with CCT (70). To date, no
clinical studies evaluating CRT response with CCT
localization of scar or dyssynchrony have been
conducted.
CCT represents a promising tool for the inves-
tigation of patients with HF. Similar to radionu-
clide assessment, CCT is associated with ionizing
radiation exposure, particularly in cases in which
retrospective electrocardiographic gating is required
Figure 9. Volume-Rendered Image of the Coronary Sinus
Volume-rendered cardiac computed tomographic image of the
coronary sinus (black arrows). The posterior vein of the left ven-
tricle (black arrowheads) and posterior interventricular vein
(white arrowheads) may also be visualized. Reprinted, with per-
mission, from Gopalan D, Raj V, Hoey ETD. Cardiac CT: non-
coronary applications. Postgrad Med J 2010;86:165–73.for acquisition of the entire cardiac cycle.
K
i
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 , 2 0 1 2
J A N U A R Y 2 0 1 2 : 9 3 – 1 1 0
Heydari et al.
Imaging for Planning of Cardiac Resynchronization Therapy
108Conclusions
CRT has demonstrated significant clinical benefits
for patients with HF refractory to medical therapy.
Despite advances in cardiac imaging over the past
decade, there are still no imaging parameters that
are routinely indicated to guide CRT therapy. To
date, the major modality investigated for dyssyn-
chrony assessment and measuring response to CRT
has been echocardiography. Despite the large body
of evidence that has quickly accrued, none of the
numerous quantitative variables from echocardiog-
raphy have been shown to achieve adequate robust-
ness to be recommended for guidance of CRT.
However, with increasing experience and technical
expertise, many echocardiographic laboratories areapy for the prevention of heart-
1
1
1
1
1
611–5.mechanical dyssynchrony. This has been coupled with
studies examining harder clinical end points for out-
come measures after CRT. Furthermore, novel imag-
ing methods have shown great promise from both a
technical and a physiological standpoint in assessing
mechanical dyssynchrony. Future randomized control
trials are required to determine whether imaging
studies can provide more targeted CRT selection to
reduce nonresponsiveness and complications related to
CRT and ultimately provide more efficient health care
expenditure.
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